Found 56 matching trials
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment
PHASE3This study will test the effectiveness of lisdexamfetamine (LDX) medication...
Location
Yale Department of Psychiatry
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
PHASE2To evaluate the efficacy of SPD489 compared to placebo in the treatment of ...
Location
Clinical Study Centers, LLC
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
PHASE4The purpose of this study is to determine effectiveness of Vyvanse compared...
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
PHASE3The primary objective of the study is to demonstrate the efficacy of SPD489...
Location
Radiant Research, Inc.
A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers
PHASE1Primary objective:
\- to investigate the effect of food on the bioavailabi...
Location
CROSS Research S.A., I Unit
The Effect of AGE on the Immune System
NAThis is a nutritional intervention study using healthy overweight/obese hum...
Location
Food Science & Human Nutrition Building, University of Florida
Attention & Memory Impairments in Menopausal Women
PHASE4The purpose of this study is to determine whether a medication called Vyvan...
Location
Penn Center for Women's Behavioral Wellness
Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17
PHASE3The main aim of this study is to see if giving LDX to children and adolesce...
Location
ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken
Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia
PHASE1This is a multiple ascending dose study; the purpose of this study is to ex...
Location
California Clinical Trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
PHASE3To evaluate the safety and tolerability of SPD489 administered as a daily m...
Location
Birmingham Research Group